Endo’s & Auxilium: When $2.2 Billion is Not Enough

Endo International (ENDP) announced that it had bid $2.2 billion to buy Auxilium Pharmaceuticals (AUXL), pricing it at $28.10 a share. MKM Partner’s Jon LeCroy doesn’t think that’s enough: Associated Press We assume that Auxilium is willing to sell itself but that Endo will need to pay more than $30.75, which is where the stock [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.